Nadya Purtova,Gijs van Maanen
Nadya Purtova
This paper provides a systematic and critical review of the economics literature on data as an economic good and draws lessons for data governance. We conclude that focusing on data as an economic good in governance efforts is hardwired to ...
Beyond categorisation: refining the relationship between subjects and objects in health research regulation [0.03%]
超越分类：在健康研究监管中完善主体和客体间的关系
Catriona McMillan,Edward Dove,Graeme Laurie et al.
Catriona McMillan et al.
In this article, we argue that the relationship between 'subject' and 'object' is poorly understood in health research regulation (HRR), and that it is a fallacy to suppose that they can operate in separate, fixed silos. By seeking to perpe...
Regulating for uncertainty: bridging blurred boundaries in medical innovation, research and treatment [0.03%]
化解医疗创新、研究和治疗的模糊边界以应对不确定性——监管的作用
Nayha Sethi
Nayha Sethi
This paper explores the blurred conceptual boundaries between 'practice/treatment', 'research' and 'medical innovation' in order to inform what these mean - and can mean - for regulation of these fields of enquiry. These terms are constantl...
Body Extension and the Law: Medical Devices, Intellectual Property, Prosthetics and Marginalisation (Again) [0.03%]
身体延伸与法律：医疗器械、知识产权、假肢及边缘化效应（再议）
Shawn H E Harmon,Abbe Brown,Sita Popat et al.
Shawn H E Harmon et al.
This interdisciplinary paper, drawing on empirical and doctrinal research regarding artificial limbs and digital avatars, analyses two concepts which are argued to be core to the person - integrity and identity. From the perspective of a pe...
Beyond regulatory compression: confronting the liminal spaces of health research regulation [0.03%]
超越监管压缩：应对健康研究监管的临界空间
Samuel Taylor-Alexander,Edward S Dove,Isabel Fletcher et al.
Samuel Taylor-Alexander et al.
Biomedicine and the life sciences continuously rearrange the relationship between culture and biology. In consequence, we increasingly look for a suitable regulatory response to reduce perceived uncertainty and instability. This article exa...
New risks inadequately managed: the case of smart implants and medical device regulation [0.03%]
新风险管控不力——以智能假体和医疗器械监管为例
Shawn H E Harmon,Gill Haddow,Leah Gilman
Shawn H E Harmon
Many emerging technologies are associated with 'risk'. While the concept of risk is protean, it is usually conceived of as the potential of something damaging or harmful happening. Thus, risks are a primary target of many regulatory regimes...
Embodied innovation and regulation of medical technoscience: transformations in cancer patienthood [0.03%]
身体化创新与医疗技术科学的规制：癌症患者身份的变化
Anne Kerr,Sarah Cunningham-Burley
Anne Kerr
Biomedical advances are transforming the diagnosis and treatment of disease. Patienthood is also transforming, as patients actively participate in research, innovation and regulation of novel technologies and therapies. In this paper we exp...